Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionBLOC-2 complex binding

RAB38 RAB32

1.59e-052802GO:0036461
GeneOntologyMolecularFunctionisocitrate dehydrogenase (NADP+) activity

IDH1 IDH2

1.59e-052802GO:0004450
GeneOntologyMolecularFunctionhistone H3T6 kinase activity

PRKCA PRKCB

1.59e-052802GO:0035403
GeneOntologyMolecularFunctiondiacylglycerol-dependent serine/threonine kinase activity

PRKCA PRKCB PRKCH

3.34e-0516803GO:0004697
GeneOntologyMolecularFunctionAP-3 adaptor complex binding

RAB38 RAB32

4.74e-053802GO:0035651
GeneOntologyMolecularFunctionisocitrate dehydrogenase [NAD(P)+] activity

IDH1 IDH2

1.57e-045802GO:0004448
GeneOntologyMolecularFunctionAP-1 adaptor complex binding

RAB38 RAB32

1.57e-045802GO:0035650
GeneOntologyMolecularFunctionG protein-coupled receptor activity

GPR146 TPRA1 OR5AK2 HTR7 OR2C3 RRH NTSR2 GPR52 LTB4R GRM8 CRHR1

7.72e-048848011GO:0004930
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

GPR146 TPRA1 OR5AK2 HTR7 OR2C3 RRH NTSR2 GPR52 LTB4R GRM8 CHRFAM7A CRHR1 CHRNA7 NRP1

8.91e-0413538014GO:0004888
GeneOntologyMolecularFunctionhistone H3 kinase activity

PRKCA PRKCB

1.02e-0312802GO:0140996
GeneOntologyMolecularFunctionacetylcholine binding

CHRFAM7A CHRNA7

1.20e-0313802GO:0042166
GeneOntologyMolecularFunctionAP-2 adaptor complex binding

RAB38 RAB32

1.40e-0314802GO:0035612
GeneOntologyMolecularFunctionG protein-coupled photoreceptor activity

RRH GPR52

1.61e-0315802GO:0008020
GeneOntologyMolecularFunctionchloride channel regulator activity

CHRFAM7A CHRNA7

1.61e-0315802GO:0017081
GeneOntologyMolecularFunctionadenylate cyclase binding

CHRFAM7A CHRNA7

1.83e-0316802GO:0008179
GeneOntologyMolecularFunctionphotoreceptor activity

RRH GPR52

2.07e-0317802GO:0009881
GeneOntologyMolecularFunctionacetylcholine-gated monoatomic cation-selective channel activity

CHRFAM7A CHRNA7

2.07e-0317802GO:0022848
GeneOntologyMolecularFunctiontoxic substance binding

CHRFAM7A CHRNA7

2.33e-0318802GO:0015643
GeneOntologyBiologicalProcesspresynaptic modulation of chemical synaptic transmission

HTR7 CHRD PRKCA PRKCB PFN2 GRM8 CHRFAM7A CHRNA7

2.15e-1067818GO:0099171
GeneOntologyBiologicalProcessmodulation of chemical synaptic transmission

PTPN5 HTR7 CHRD PRKCA PRKCB PLCL1 PFN2 SLC30A1 ZZEF1 GRM8 CHRFAM7A CRHR1 CHRNA7

1.75e-066638113GO:0050804
GeneOntologyBiologicalProcessregulation of trans-synaptic signaling

PTPN5 HTR7 CHRD PRKCA PRKCB PLCL1 PFN2 SLC30A1 ZZEF1 GRM8 CHRFAM7A CRHR1 CHRNA7

1.78e-066648113GO:0099177
GeneOntologyBiologicalProcesspositive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure

CHRFAM7A CHRNA7

1.52e-052812GO:0001988
GeneOntologyBiologicalProcessglyoxylate cycle

IDH1 IDH2

1.52e-052812GO:0006097
GeneOntologyBiologicalProcesslong-term synaptic potentiation

PTPN5 HTR7 CHRD CHRFAM7A CRHR1 CHRNA7

2.20e-05144816GO:0060291
GeneOntologyBiologicalProcessdendrite arborization

CHRFAM7A CHRNA7 NRP1

2.57e-0515813GO:0140059
GeneOntologyBiologicalProcessbehavioral response to ethanol

CHRFAM7A CRHR1 CHRNA7

3.81e-0517813GO:0048149
GeneOntologyBiologicalProcessresponse to ethanol

AACS PRKCA PRKCB CHRFAM7A CRHR1 CHRNA7

4.12e-05161816GO:0045471
GeneOntologyBiologicalProcessbaroreceptor response to decreased systemic arterial blood pressure

CHRFAM7A CHRNA7

4.56e-053812GO:0001982
GeneOntologyBiologicalProcessanterograde trans-synaptic signaling

PTPN5 HTR7 CHRD PRKCA PRKCB PLCL1 PFN2 SLC30A1 ZZEF1 GRM8 CHRFAM7A CRHR1 CHRNA7

6.46e-059318113GO:0098916
GeneOntologyBiologicalProcesschemical synaptic transmission

PTPN5 HTR7 CHRD PRKCA PRKCB PLCL1 PFN2 SLC30A1 ZZEF1 GRM8 CHRFAM7A CRHR1 CHRNA7

6.46e-059318113GO:0007268
GeneOntologyBiologicalProcessregulation of secretion

PLA2R1 HTR7 AACS PRKCA PRKCB IDH2 PFN2 SLC30A1 GRM8 CHRFAM7A CRHR1 CHRNA7

6.53e-058018112GO:0051046
GeneOntologyBiologicalProcesstrans-synaptic signaling

PTPN5 HTR7 CHRD PRKCA PRKCB PLCL1 PFN2 SLC30A1 ZZEF1 GRM8 CHRFAM7A CRHR1 CHRNA7

7.04e-059398113GO:0099537
GeneOntologyBiologicalProcessregulation of response to drug

PTPN5 CHRFAM7A CHRNA7

7.37e-0521813GO:2001023
GeneOntologyBiologicalProcessgeneration of ovulation cycle rhythm

CHRFAM7A CHRNA7

9.09e-054812GO:0060112
GeneOntologyBiologicalProcessmonoamine transport

HTR7 PRKCB CHRFAM7A CRHR1 CHRNA7

9.40e-05116815GO:0015844
GeneOntologyBiologicalProcessregulation of neurotransmitter secretion

PRKCA PRKCB PFN2 SLC30A1 GRM8

1.02e-04118815GO:0046928
GeneOntologyBiologicalProcesssynaptic signaling

PTPN5 HTR7 CHRD PRKCA PRKCB PLCL1 PFN2 SLC30A1 ZZEF1 GRM8 CHRFAM7A CRHR1 CHRNA7

1.04e-049768113GO:0099536
GeneOntologyBiologicalProcesslearning or memory

HTR7 CHRD PRKCA MDK ZZEF1 CHRFAM7A CRHR1 CHRNA7

1.08e-04373818GO:0007611
GeneOntologyBiologicalProcessregulation of catecholamine secretion

PRKCB CHRFAM7A CRHR1 CHRNA7

1.40e-0467814GO:0050433
GeneOntologyBiologicalProcessregulation of secretion by cell

HTR7 AACS PRKCA PRKCB IDH2 PFN2 SLC30A1 GRM8 CHRFAM7A CRHR1 CHRNA7

1.45e-047408111GO:1903530
GeneOntologyBiologicalProcesspositive regulation of smooth muscle cell chemotaxis

MDK NRP1

1.51e-045812GO:0071673
GeneOntologyBiologicalProcesssensory processing

CHRFAM7A CHRNA7

1.51e-045812GO:0050893
GeneOntologyBiologicalProcessregulation of synaptic plasticity

PTPN5 HTR7 CHRD ZZEF1 CHRFAM7A CRHR1 CHRNA7

1.54e-04293817GO:0048167
GeneOntologyBiologicalProcessassociative learning

CHRD ZZEF1 CHRFAM7A CRHR1 CHRNA7

1.61e-04130815GO:0008306
GeneOntologyBiologicalProcessregulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback

CHRFAM7A CHRNA7

2.26e-046812GO:0001978
GeneOntologyBiologicalProcessisocitrate metabolic process

IDH1 IDH2

2.26e-046812GO:0006102
GeneOntologyBiologicalProcessresponse to alcohol

HTR7 AACS PRKCA PRKCB CHRFAM7A CRHR1 CHRNA7

2.26e-04312817GO:0097305
GeneOntologyBiologicalProcesssignal release

HTR7 AACS PRKCA PRKCB PFN2 SLC30A1 GRM8 CHRFAM7A CRHR1 CHRNA7

2.34e-046538110GO:0023061
GeneOntologyBiologicalProcessregulation of neurotransmitter transport

PRKCA PRKCB PFN2 SLC30A1 GRM8

2.35e-04141815GO:0051588
GeneOntologyBiologicalProcesscognition

HTR7 CHRD PRKCA MDK ZZEF1 CHRFAM7A CRHR1 CHRNA7

2.55e-04423818GO:0050890
GeneOntologyBiologicalProcesssecretion

PLA2R1 HTR7 PRSS12 AACS PRKCA PRKCB IDH2 PFN2 SLC30A1 GRM8 MUC2 CHRFAM7A CRHR1 CHRNA7

2.64e-0412218114GO:0046903
GeneOntologyBiologicalProcesscatecholamine secretion

PRKCB CHRFAM7A CRHR1 CHRNA7

2.65e-0479814GO:0050432
GeneOntologyBiologicalProcesspositive regulation of synaptic transmission

PTPN5 HTR7 CHRD CHRFAM7A CRHR1 CHRNA7

3.12e-04233816GO:0050806
GeneOntologyBiologicalProcesspositive regulation of long-term synaptic potentiation

PTPN5 CHRFAM7A CHRNA7

3.20e-0434813GO:1900273
GeneOntologyBiologicalProcessmitotic nuclear membrane disassembly

PRKCA PRKCB

4.20e-048812GO:0007077
GeneOntologyBiologicalProcessglyoxylate metabolic process

IDH1 IDH2

4.20e-048812GO:0046487
GeneOntologyBiologicalProcessregulation of systemic arterial blood pressure by baroreceptor feedback

CHRFAM7A CHRNA7

4.20e-048812GO:0003025
GeneOntologyBiologicalProcessneuron projection arborization

CHRFAM7A CHRNA7 NRP1

4.46e-0438813GO:0140058
GeneOntologyBiologicalProcessregulation of smooth muscle cell chemotaxis

MDK NRP1

5.39e-049812GO:0071671
GeneOntologyBiologicalProcesspositive regulation of CoA-transferase activity

CHRFAM7A CHRNA7

5.39e-049812GO:1905920
GeneOntologyBiologicalProcesscatecholamine transport

PRKCB CHRFAM7A CRHR1 CHRNA7

5.57e-0496814GO:0051937
GeneOntologyBiologicalProcesspositive regulation of B cell receptor signaling pathway

PRKCB PRKCH

6.72e-0410812GO:0050861
GeneOntologyBiologicalProcessendosome to melanosome transport

RAB38 RAB32

6.72e-0410812GO:0035646
GeneOntologyBiologicalProcessendosome to pigment granule transport

RAB38 RAB32

6.72e-0410812GO:0043485
GeneOntologyBiologicalProcesspigment granule maturation

RAB38 RAB32

6.72e-0410812GO:0048757
GeneOntologyBiologicalProcessmemory

HTR7 MDK CHRFAM7A CRHR1 CHRNA7

7.73e-04183815GO:0007613
GeneOntologyBiologicalProcesssmooth muscle cell chemotaxis

MDK NRP1

8.19e-0411812GO:0071670
GeneOntologyBiologicalProcessregulation of CoA-transferase activity

CHRFAM7A CHRNA7

8.19e-0411812GO:1905918
GeneOntologyBiologicalProcessnegative regulation of glial cell apoptotic process

PRKCA PRKCH

8.19e-0411812GO:0034351
GeneOntologyBiologicalProcessbehavioral response to nicotine

CHRFAM7A CHRNA7

8.19e-0411812GO:0035095
GeneOntologyBiologicalProcesssecretion by cell

HTR7 PRSS12 AACS PRKCA PRKCB IDH2 PFN2 SLC30A1 GRM8 CHRFAM7A CRHR1 CHRNA7

8.77e-0410648112GO:0032940
GeneOntologyBiologicalProcessregulation of synapse structural plasticity

CHRFAM7A CHRNA7

9.80e-0412812GO:0051823
GeneOntologyBiologicalProcesspigment accumulation

RAB38 RAB32

9.80e-0412812GO:0043476
GeneOntologyBiologicalProcesscellular pigment accumulation

RAB38 RAB32

9.80e-0412812GO:0043482
GeneOntologyBiologicalProcessexploration behavior

PTPN5 CHRD CRHR1

1.00e-0350813GO:0035640
GeneOntologyBiologicalProcesssignal release from synapse

PRKCA PRKCB PFN2 SLC30A1 GRM8

1.03e-03195815GO:0099643
GeneOntologyBiologicalProcessneurotransmitter secretion

PRKCA PRKCB PFN2 SLC30A1 GRM8

1.03e-03195815GO:0007269
GeneOntologyBiologicalProcessacetylcholine receptor signaling pathway

PRKCB CHRFAM7A CHRNA7

1.06e-0351813GO:0095500
GeneOntologyBiologicalProcessregulation of synaptic transmission, dopaminergic

CHRFAM7A CHRNA7

1.16e-0313812GO:0032225
GeneOntologyBiologicalProcessnuclear membrane disassembly

PRKCA PRKCB

1.16e-0313812GO:0051081
GeneOntologyBiologicalProcesscellular response to acetylcholine

PRKCB CHRFAM7A CHRNA7

1.19e-0353813GO:1905145
GeneOntologyBiologicalProcesspeptidyl-serine phosphorylation

PRKCA PRKCB PRKCH PFN2 CHRFAM7A CHRNA7

1.32e-03307816GO:0018105
GeneOntologyBiologicalProcessmembrane disassembly

PRKCA PRKCB

1.34e-0314812GO:0030397
GeneOntologyBiologicalProcessresponse to acetylcholine

PRKCB CHRFAM7A CHRNA7

1.39e-0356813GO:1905144
GeneOntologyBiologicalProcesslearning

CHRD ZZEF1 CHRFAM7A CRHR1 CHRNA7

1.49e-03212815GO:0007612
GeneOntologyBiologicalProcessregulation of amine transport

PRKCB CHRFAM7A CRHR1 CHRNA7

1.49e-03125814GO:0051952
GeneOntologyCellularComponentspine apparatus membrane

CHRFAM7A CHRNA7

4.44e-053812GO:0098897
GeneOntologyCellularComponentpresynapse

PTPN5 CLCN5 HTR7 PRSS12 PRKCA PRKCB PFN2 ZZEF1 GRM8 CHRFAM7A CHRNA7 SENP5

1.49e-048868112GO:0098793
GeneOntologyCellularComponentearly endosome lumen

RAB38 RAB32

2.20e-046812GO:0031905
GeneOntologyCellularComponentsynaptic membrane

PTPN5 HTR7 BCAN SLC30A1 GRM8 CHRFAM7A CRHR1 CHRNA7 NRP1

4.20e-04583819GO:0097060
GeneOntologyCellularComponentdendrite

PTPN5 HTR7 PRSS12 ELOVL5 NTSR2 PRKCA BCAN SLC30A1 CHRFAM7A CRHR1 CHRNA7

4.59e-048588111GO:0030425
GeneOntologyCellularComponentdendritic tree

PTPN5 HTR7 PRSS12 ELOVL5 NTSR2 PRKCA BCAN SLC30A1 CHRFAM7A CRHR1 CHRNA7

4.68e-048608111GO:0097447
GeneOntologyCellularComponentspine apparatus

CHRFAM7A CHRNA7

5.25e-049812GO:0097444
GeneOntologyCellularComponentsomatodendritic compartment

PTPN5 HTR7 PRSS12 ELOVL5 NTSR2 PRKCA BCAN SLC30A1 GRM8 CHRFAM7A CRHR1 CHRNA7 NRP1

8.36e-0412288113GO:0036477
GeneOntologyCellularComponentcell body

RAB38 PTPN5 HTR7 ELOVL5 NTSR2 PRKCA GRM8 CHRFAM7A CRHR1 CHRNA7 NRP1

8.87e-049298111GO:0044297
GeneOntologyCellularComponentpresynaptic cytosol

PRKCA PRKCB SENP5

9.08e-0449813GO:0099523
GeneOntologyCellularComponentextracellular matrix

BMP1 OTOGL PAPLN MUC5B BCAN MDK MUC2 ANGPTL1 ITIH2

9.74e-04656819GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

BMP1 OTOGL PAPLN MUC5B BCAN MDK MUC2 ANGPTL1 ITIH2

9.95e-04658819GO:0030312
GeneOntologyCellularComponentneuronal cell body

PTPN5 HTR7 ELOVL5 NTSR2 PRKCA GRM8 CHRFAM7A CRHR1 CHRNA7 NRP1

1.42e-038358110GO:0043025
GeneOntologyCellularComponentdistal axon

HTR7 PRSS12 PRKCA PRKCB CHRFAM7A CHRNA7 NRP1

1.49e-03435817GO:0150034
GeneOntologyCellularComponentacetylcholine-gated channel complex

CHRFAM7A CHRNA7

2.18e-0318812GO:0005892
GeneOntologyCellularComponentcytosolic region

PRKCA PRKCB SENP5

2.55e-0370813GO:0099522
GeneOntologyCellularComponentglycinergic synapse

CHRFAM7A CHRNA7

2.69e-0320812GO:0098690
GeneOntologyCellularComponentaxolemma

CHRFAM7A CHRNA7

2.97e-0321812GO:0030673
GeneOntologyCellularComponentdendritic shaft

NTSR2 CHRFAM7A CHRNA7

2.98e-0374813GO:0043198
GeneOntologyCellularComponentcholinergic synapse

CHRFAM7A CHRNA7

3.26e-0322812GO:0098981
GeneOntologyCellularComponentpigment granule membrane

RAB38 RAB32

3.26e-0322812GO:0090741
GeneOntologyCellularComponentchitosome

RAB38 RAB32

3.26e-0322812GO:0045009
GeneOntologyCellularComponentmelanosome membrane

RAB38 RAB32

3.26e-0322812GO:0033162
GeneOntologyCellularComponentmitochondria-associated endoplasmic reticulum membrane contact site

RAB38 RAB32

3.56e-0323812GO:0044233
GeneOntologyCellularComponentcollagen-containing extracellular matrix

BMP1 PAPLN BCAN MDK MUC2 ANGPTL1 ITIH2

4.47e-03530817GO:0062023
GeneOntologyCellularComponentpostsynaptic membrane

HTR7 SLC30A1 CHRFAM7A CRHR1 CHRNA7 NRP1

4.88e-03405816GO:0045211
GeneOntologyCellularComponentmain axon

BCAN CHRFAM7A CHRNA7

5.01e-0389813GO:0044304
MousePhenoairway basal cell hyperplasia

CHRFAM7A CHRNA7

2.40e-052692MP:0011115
MousePhenoabnormal airway basal cell differentiation

CHRFAM7A CHRNA7

2.40e-052692MP:0011114
MousePhenoabnormal airway basal cell morphology

CHRFAM7A CHRNA7

2.40e-052692MP:0011113
DomainIsocitrate_DH_NADP

IDH1 IDH2

1.81e-052802IPR004790
DomainProtein_kinase_C_a/b/g

PRKCA PRKCB

5.42e-053802IPR014375
DomainDAG/PE-bd

PRKCA PRKCB PRKCH

9.52e-0521803IPR020454
DomainACAS_N

ACSS1 AACS

1.08e-044802PF16177
DomainACAS_N

ACSS1 AACS

1.08e-044802IPR032387
DomainIso_dh

IDH1 IDH2

1.80e-045802SM01329
DomainIDH_IMDH

IDH1 IDH2

1.80e-045802PS00470
DomainIsocitrate/isopropylmalate_DH

IDH1 IDH2

1.80e-045802IPR001804
DomainIso_dh

IDH1 IDH2

1.80e-045802PF00180
DomainIsoPropMal-DH-like_dom

IDH1 IDH2

1.80e-045802IPR024084
DomainIsoCit/isopropylmalate_DH_CS

IDH1 IDH2

1.80e-045802IPR019818
Domain-

IDH1 IDH2

1.80e-0458023.40.718.10
DomainRICIN

PLA2R1 MRC2 CRYBG1

2.29e-0428803SM00458
DomainRICIN_B_LECTIN

PLA2R1 MRC2 CRYBG1

2.29e-0428803PS50231
DomainWxxW_domain

MUC5B MUC2

2.69e-046802IPR025155
DomainMucin2_WxxW

MUC5B MUC2

2.69e-046802PF13330
DomainRicin_B_lectin

PLA2R1 MRC2 CRYBG1

2.83e-0430803IPR000772
DomainKringle-like

PLA2R1 PRSS12 MRC2

3.43e-0432803IPR013806
DomainTLV_coat

ERVFC1 ERVMER34-1

3.75e-047802PF00429
DomainVWFC_1

CHRD MUC5B MUC2

4.88e-0436803PS01208
DomainTLV/ENV_coat_polyprotein

ERVFC1 ERVMER34-1

4.99e-048802IPR018154
DomainPkinase_C

PRKCA PRKCB PRKCH

5.29e-0437803IPR017892
DomainVWC

CHRD MUC5B MUC2

5.73e-0438803SM00214
DomainVWFC_2

CHRD MUC5B MUC2

5.73e-0438803PS50184
DomainPkinase_C

PRKCA PRKCB PRKCH

7.70e-0442803PF00433
DomainVWF_dom

CHRD MUC5B MUC2

7.70e-0442803IPR001007
DomainC-type_lectin_CS

PLA2R1 MRC2 BCAN

8.25e-0443803IPR018378
DomainTIL

MUC5B MUC2

1.16e-0312802PF01826
DomainC8

MUC5B MUC2

1.16e-0312802PF08742
DomainSTART

STARD13 CERT1

1.37e-0313802SM00234
DomainUnchr_dom_Cys-rich

MUC5B MUC2

1.37e-0313802IPR014853
DomainC8

MUC5B MUC2

1.37e-0313802SM00832
Domain-

PLA2R1 MRC2

1.37e-03138022.10.10.10
Domain-

BMP1 ZZEF1 NRP1

1.44e-03528032.60.120.290
DomainFN_type2_col-bd

PLA2R1 MRC2

1.59e-0314802IPR000562
DomainFN2_2

PLA2R1 MRC2

1.59e-0314802PS51092
DomainTIL_dom

MUC5B MUC2

1.59e-0314802IPR002919
Domainfn2

PLA2R1 MRC2

1.59e-0314802PF00040
DomainFN2_1

PLA2R1 MRC2

1.59e-0314802PS00023
DomainFN2

PLA2R1 MRC2

1.59e-0314802SM00059
DomainAGC-kinase_C

PRKCA PRKCB PRKCH

1.78e-0356803IPR000961
DomainAGC_KINASE_CTER

PRKCA PRKCB PRKCH

1.78e-0356803PS51285
DomainS_TK_X

PRKCA PRKCB PRKCH

1.78e-0356803SM00133
DomainSTART

STARD13 CERT1

1.83e-0315802PF01852
DomainSTART_lipid-bd_dom

STARD13 CERT1

1.83e-0315802IPR002913
DomainSTART

STARD13 CERT1

1.83e-0315802PS50848
DomainCUB_dom

BMP1 ZZEF1 NRP1

1.87e-0357803IPR000859
DomainC1_1

PRKCA PRKCB PRKCH

1.87e-0357803PF00130
DomainVWD

MUC5B MUC2

2.09e-0316802SM00216
DomainVWF_type-D

MUC5B MUC2

2.09e-0316802IPR001846
DomainVWFD

MUC5B MUC2

2.09e-0316802PS51233
DomainVWD

MUC5B MUC2

2.09e-0316802PF00094
DomainC2

PRKCA PRKCB PRKCH PLCL1

2.42e-03131804PF00168
DomainZF_DAG_PE_1

PRKCA PRKCB PRKCH

2.61e-0364803PS00479
DomainZF_DAG_PE_2

PRKCA PRKCB PRKCH

2.61e-0364803PS50081
DomainCTCK_1

MUC5B MUC2

2.65e-0318802PS01185
DomainC1

PRKCA PRKCB PRKCH

2.73e-0365803SM00109
DomainC2

PRKCA PRKCB PRKCH PLCL1

2.85e-03137804SM00239
DomainPE/DAG-bd

PRKCA PRKCB PRKCH

2.85e-0366803IPR002219
DomainVWC_out

MUC5B MUC2

2.96e-0319802SM00215
DomainC2

PRKCA PRKCB PRKCH PLCL1

3.24e-03142804PS50004
Domain-

PRKCA PRKCB PRKCH PLCL1

3.76e-031488042.60.40.150
DomainCT

MUC5B MUC2

3.96e-0322802SM00041
PathwayBIOCARTA_ION_PATHWAY

PRKCA PRKCB

2.48e-045712MM1574
PathwayBIOCARTA_PLCD_PATHWAY

PRKCA PRKCB

2.48e-045712MM1587
PathwayBIOCARTA_ION_PATHWAY

PRKCA PRKCB

2.48e-045712M22059
PathwayBIOCARTA_PLCD_PATHWAY

PRKCA PRKCB

2.48e-045712M22080
PathwayREACTOME_DISINHIBITION_OF_SNARE_FORMATION

PRKCA PRKCB

2.48e-045712M26920
PathwayPID_VEGFR1_PATHWAY

PRKCA PRKCB NRP1

2.93e-0426713M226
PathwayBIOCARTA_ERBB4_PATHWAY

PRKCA PRKCB

5.17e-047712MM1563
PathwayBIOCARTA_PKC_PATHWAY

PRKCA PRKCB

5.17e-047712MM1572
PathwayBIOCARTA_ERBB4_PATHWAY

PRKCA PRKCB

5.17e-047712M22043
PathwayBIOCARTA_PKC_PATHWAY

PRKCA PRKCB

5.17e-047712M22057
PathwayWP_CYTOSINE_METHYLATION

IDH1 IDH2

6.87e-048712M39348
PathwayKEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB

6.87e-048712M47555
PathwayKEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY

PRKCA PRKCB

6.87e-048712M47479
PathwayBIOCARTA_PLC_PATHWAY

PRKCA PRKCB

8.80e-049712M22029
PathwayBIOCARTA_PLC_PATHWAY

PRKCA PRKCB

8.80e-049712MM1551
PathwayKEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION

IDH1 IDH2

8.80e-049712M47937
PathwayWP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY

PRKCA PRKCB PRKCH

9.82e-0439713M39905
PathwayBIOCARTA_SRCRPTP_PATHWAY

PRKCA PRKCB

1.10e-0310712MM1341
PathwayBIOCARTA_AGPCR_PATHWAY

PRKCA PRKCB

1.10e-0310712MM1352
PathwayKEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY

PRKCA PRKCB

1.10e-0310712M47644
PathwayBIOCARTA_CBL_PATHWAY

PRKCA PRKCB

1.34e-0311712MM1360
PathwayKEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB

1.34e-0311712M47637
PathwayBIOCARTA_SRCRPTP_PATHWAY

PRKCA PRKCB

1.34e-0311712M10994
PathwayBIOCARTA_MYOSIN_PATHWAY

PRKCA PRKCB

1.34e-0311712M7014
PathwayBIOCARTA_AGPCR_PATHWAY

PRKCA PRKCB

1.34e-0311712M19829
PathwayBIOCARTA_KERATINOCYTE_PATHWAY

PRKCA PRKCB PRKCH

1.59e-0346713M19118
PathwayBIOCARTA_KERATINOCYTE_PATHWAY

PRKCA PRKCB PRKCH

1.59e-0346713MM1428
PathwayWP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION

PRKCA PRKCB PRKCH

1.59e-0346713M46450
PathwayKEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY

PRKCA PRKCB

1.60e-0312712M47597
PathwayKEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB

1.60e-0312712M47649
PathwayREACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS

CHRFAM7A CHRNA7

1.60e-0312712MM15312
PathwayKEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY

PRKCA PRKCB

1.60e-0312712M47628
PathwayBIOCARTA_CBL_PATHWAY

PRKCA PRKCB

1.60e-0312712M16973
PathwayWP_WNT_SIGNALING_AND_PLURIPOTENCY

PRKCA PRKCB PRKCH PPM1J

1.67e-03101714M39387
PathwayWP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY

PRKCA PRKCB PRKCH PPM1J

1.67e-03101714MM15829
PathwayREACTOME_G_ALPHA_Z_SIGNALLING_EVENTS

PRKCA PRKCB PRKCH

1.80e-0348713M10775
PathwayKEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY

PRKCA PRKCB

1.88e-0313712M47656
PathwayWP_SEROTONIN_AND_ANXIETYRELATED_EVENTS

PRKCB CRHR1

1.88e-0313712MM15819
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY

PRKCA PRKCB

2.19e-0314712M47383
PathwayKEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY

PRKCA PRKCB

2.19e-0314712M47384
PathwayPID_TCR_RAS_PATHWAY

PRKCA PRKCB

2.19e-0314712M134
PathwayWP_SEROTONIN_AND_ANXIETYRELATED_EVENTS

PRKCB CRHR1

2.19e-0314712M39614
PathwayBIOCARTA_TRKA_PATHWAY

PRKCA PRKCB

2.19e-0314712M9134
PathwayWP_GPCRS_NONODORANT

HTR7 RRH NTSR2 LTB4R GRM8 CRHR1

2.19e-03266716MM15843
PathwayPID_NFAT_3PATHWAY

PRKCA PRKCB PRKCH

2.39e-0353713M113
PathwayKEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION

HTR7 NTSR2 LTB4R GRM8 CRHR1 CHRNA7

2.45e-03272716M13380
PathwayBIOCARTA_CDMAC_PATHWAY

PRKCA PRKCB

2.52e-0315712MM1358
PathwayBIOCARTA_TRKA_PATHWAY

PRKCA PRKCB

2.52e-0315712MM1523
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY

PRKCA PRKCB

2.52e-0315712M47382
PathwayREACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA

PRKCA PRKCB

2.52e-0315712M27360
PathwayREACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4

PRKCA PRKCB

2.52e-0315712M27413
PathwayREACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS

CHRFAM7A CHRNA7

2.52e-0315712MM14704
PathwayKEGG_VIBRIO_CHOLERAE_INFECTION

PRKCA PRKCB MUC2

2.53e-0354713M17906
PathwayREACTOME_SIGNALING_BY_GPCR

ARHGEF40 HTR7 RRH NTSR2 PRKCA PRKCB PRKCH LTB4R GRM8 CRHR1

2.59e-037027110M746
PathwayPID_TXA2PATHWAY

PRKCA PRKCB PRKCH

2.80e-0356713M99
PathwayBIOCARTA_MEF2D_PATHWAY

PRKCA PRKCB

2.87e-0316712MM1483
PathwayBIOCARTA_SPPA_PATHWAY

PRKCA PRKCB

2.87e-0316712M8731
PathwayBIOCARTA_CDMAC_PATHWAY

PRKCA PRKCB

2.87e-0316712M4388
PathwayBIOCARTA_CCR5_PATHWAY

PRKCA PRKCB

3.24e-0317712M2349
PathwayREACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS

PRKCA PRKCB

3.24e-0317712M5488
PathwayWP_WNT_SIGNALING

PRKCA PRKCB PRKCH

3.58e-0361713MM15893
PathwayBIOCARTA_CHEMICAL_PATHWAY

PRKCA PRKCB

3.63e-0318712MM1350
PathwayBIOCARTA_CARDIACEGF_PATHWAY

PRKCA PRKCB

3.63e-0318712M7552
PathwayBIOCARTA_MEF2D_PATHWAY

PRKCA PRKCB

3.63e-0318712M5290
PathwayBIOCARTA_CALCINEURIN_PATHWAY

PRKCA PRKCB

3.63e-0318712MM1385
PathwayBIOCARTA_CALCINEURIN_PATHWAY

PRKCA PRKCB

3.63e-0318712M3430
PathwayBIOCARTA_CARDIACEGF_PATHWAY

PRKCA PRKCB

3.63e-0318712MM1479
PathwayBIOCARTA_CHEMICAL_PATHWAY

PRKCA PRKCB

3.63e-0318712M3873
PathwayPID_ENDOTHELIN_PATHWAY

PRKCA PRKCB PRKCH

3.92e-0363713M8
PathwayBIOCARTA_CCR3_PATHWAY

PRKCA PRKCB

4.05e-0319712MM1361
PathwayKEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY

PRKCA PRKCB

4.05e-0319712M47596
PathwayBIOCARTA_PAR1_PATHWAY

PRKCA PRKCB

4.05e-0319712MM1514
PathwayBIOCARTA_CXCR4_PATHWAY

PRKCA PRKCB

4.05e-0319712MM1375
PathwayBIOCARTA_CXCR4_PATHWAY

PRKCA PRKCB

4.05e-0319712M882
PathwayBIOCARTA_CCR5_PATHWAY

PRKCA PRKCB

4.05e-0319712MM1453
PathwayREACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION

PRKCA PRKCB

4.05e-0319712M27423
PathwayBIOCARTA_PAR1_PATHWAY

PRKCA PRKCB

4.05e-0319712M3494
PathwayBIOCARTA_CCR3_PATHWAY

PRKCA PRKCB

4.05e-0319712M9152
PathwayWP_ONCOSTATIN_M_SIGNALING

PRKCA PRKCB PRKCH

4.28e-0365713M39562
PathwayBIOCARTA_CREB_PATHWAY

PRKCA PRKCB

4.48e-0320712MM1520
PathwayBIOCARTA_NOS1_PATHWAY

PRKCA PRKCB

4.48e-0320712MM1445
PathwayBIOCARTA_EDG1_PATHWAY

PRKCA PRKCB

4.48e-0320712MM1456
PathwayBIOCARTA_ARENRF2_PATHWAY

PRKCA PRKCB

4.48e-0320712M14339
PathwayKEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB

4.94e-0321712M47638
PathwayBIOCARTA_NOS1_PATHWAY

PRKCA PRKCB

4.94e-0321712M11650
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC5B MUC2

4.94e-0321712MM15706
Pubmed

Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.

TPRA1 MRC2 CHRD PRKCA PAPLN PRKCH MDK CERT1

3.76e-0821082816537572
Pubmed

Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes.

PRKCA PRKCB PRKCH

5.04e-08482326404773
Pubmed

A hippocampal nicotinic acetylcholine alpha 7-containing receptor complex is linked to memory retrieval in the multiple-T-maze in C57BL/6j mice.

HTR7 CHRFAM7A CHRNA7

1.26e-07582324837029
Pubmed

Protein kinase C isoform expression and activity in the mouse heart.

PRKCA PRKCB PRKCH

2.51e-07682311668067
Pubmed

Translocation of diacylglycerol kinase theta from cytosol to plasma membrane in response to activation of G protein-coupled receptors and protein kinase C.

PRKCA PRKCB PRKCH

2.51e-07682315632189
Pubmed

Regulation of NMDA receptor trafficking by amyloid-beta.

PTPN5 CHRFAM7A CHRNA7

4.39e-07782316025111
Pubmed

The Protein-tyrosine-phosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase C isoforms alpha, beta 1, beta 2, and eta.

PRKCA PRKCB PRKCH

4.39e-07782311781100
Pubmed

Distribution of the extended family of protein kinase C isoenzymes in fetal organs of mice: an immunohistochemical study.

PRKCA PRKCB PRKCH

7.01e-0788237606770
Pubmed

aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb.

PRKCA PRKCB PRKCH

1.05e-06982317203073
Pubmed

Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope glycoprotein.

PRKCA PRKCB PRKCH

1.05e-0698237850771
Pubmed

Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary report.

PRKCA PRKCB PRKCH

1.05e-0698238206685
Pubmed

Regulation of HIV-1 gag protein subcellular targeting by protein kinase C.

PRKCA PRKCB PRKCH

1.05e-0698237876252
Pubmed

Phosphorylation of HIV-1 gag proteins by protein kinase C.

PRKCA PRKCB PRKCH

1.05e-0698238473314
Pubmed

Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes.

PRKCA PRKCB PRKCH

1.05e-06982311700305
Pubmed

The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway.

PRKCA PRKCB PRKCH

1.50e-06108231970444
Pubmed

Human immunodeficiency virus induces phosphorylation of its cell surface receptor.

PRKCA PRKCB PRKCH

1.50e-06108233259291
Pubmed

Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

PRKCA PRKCB PRKCH

1.50e-061082311884598
Pubmed

Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.

PRKCA PRKCB PRKCH

1.50e-061082310491200
Pubmed

Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.

PRKCA PRKCB PRKCH

1.50e-06108232139676
Pubmed

Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.

PRKCA PRKCB PRKCH

2.06e-061182314613966
Pubmed

IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C.

PRKCA PRKCB PRKCH

2.06e-06118238599832
Pubmed

Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C.

PRKCA PRKCB PRKCH

2.06e-06118232182321
Pubmed

In vitro phosphorylation of human immunodeficiency virus type 1 Tat protein by protein kinase C: evidence for the phosphorylation of amino acid residue serine-46.

PRKCA PRKCB PRKCH

2.06e-06118238914829
Pubmed

Expression profile of protein kinase C isozymes in preimplantation mouse development.

PRKCA PRKCB PRKCH

2.06e-061182316183862
Pubmed

Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium.

PRKCA PRKCB PRKCH

2.74e-061282311141237
Pubmed

HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier?

PRKCA PRKCB PRKCH

2.74e-061282318577246
Pubmed

c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells.

PRKCA PRKCB PRKCH

2.74e-061282319363595
Pubmed

HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta.

PRKCA PRKCB PRKCH

2.74e-061282311919157
Pubmed

HIV-1 reverse transcriptase is phosphorylated in vitro and in a cellular system.

PRKCA PRKCB PRKCH

3.55e-061382310641798
Pubmed

The inhibition of differentiation caused by TGFbeta in fetal myoblasts is dependent upon selective expression of PKCtheta: a possible molecular basis for myoblast diversification during limb histogenesis.

PRKCA PRKCB PRKCH

3.55e-06138238948582
Pubmed

EGF-stimulated signaling by means of PI3K, PLCgamma1, and PKC isozymes regulates branching morphogenesis of the fetal mouse submandibular gland.

PRKCA PRKCB PRKCH

3.55e-061382312761849
Pubmed

HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells.

PRKCA PRKCB PRKCH

4.51e-06148237642615
Pubmed

IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: A report of 311 Chinese adult glioma patients.

IDH1 IDH2

5.49e-06282225524848
Pubmed

Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas.

IDH1 IDH2

5.49e-06282230194083
Pubmed

Enhancing cognitive function in chronic TBI: The Role of α7 nicotinic acetylcholine receptor modulation.

CHRFAM7A CHRNA7

5.49e-06282238070724
Pubmed

Metabolism unhinged: IDH mutations in cancer.

IDH1 IDH2

5.49e-06282221383741
Pubmed

IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?

IDH1 IDH2

5.49e-06282230176240
Pubmed

Inflammatory cytokines decrease the expression of nicotinic acetylcholine receptor during the cell maturation.

CHRFAM7A CHRNA7

5.49e-06282219626424
Pubmed

Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.

IDH1 IDH2

5.49e-06282223494632
Pubmed

IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC.

IDH1 IDH2

5.49e-06282227548812
Pubmed

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.

IDH1 IDH2

5.49e-06282234078652
Pubmed

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.

IDH1 IDH2

5.49e-06282223894344
Pubmed

Episodic memory performance predicted by the 2bp deletion in exon 6 of the "alpha 7-like" nicotinic receptor subunit gene.

CHRFAM7A CHRNA7

5.49e-06282217012698
Pubmed

High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei.

IDH1 IDH2

5.49e-06282221480859
Pubmed

IDH-Mutant Tumors Vulnerable to PARP Inhibition.

IDH1 IDH2

5.49e-06282228228392
Pubmed

Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.

IDH1 IDH2

5.49e-06282223361564
Pubmed

Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose.

PRKCA PRKCB

5.49e-06282226660275
Pubmed

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

IDH1 IDH2

5.49e-06282229472349
Pubmed

Study of mutations in IDH1 and IDH2 genes in a sample of gliomas from Colombian population.

IDH1 IDH2

5.49e-06282229874711
Pubmed

Cholinergic Pathway Suppresses Pulmonary Innate Immunity Facilitating Pneumonia After Stroke.

CHRFAM7A CHRNA7

5.49e-06282226451017
Pubmed

Genetic deletion of α7 nicotinic acetylcholine receptors induces an age-dependent Alzheimer's disease-like pathology.

CHRFAM7A CHRNA7

5.49e-06282234453977
Pubmed

Perinatal hypoxia-ischemia reduces α 7 nicotinic receptor expression and selective α 7 nicotinic receptor stimulation suppresses inflammation and promotes microglial Mox phenotype.

CHRFAM7A CHRNA7

5.49e-06282224757672
Pubmed

IDH mutation detection in formalin-fixed paraffin-embedded gliomas using multiplex PCR and single-base extension.

IDH1 IDH2

5.49e-06282222360629
Pubmed

Inhibition of pancreatic acinar mitochondrial thiamin pyrophosphate uptake by the cigarette smoke component 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

CHRFAM7A CHRNA7

5.49e-06282226999808
Pubmed

Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.

IDH1 IDH2

5.49e-06282222503487
Pubmed

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

IDH1 IDH2

5.49e-06282220171147
Pubmed

Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.

CHRFAM7A CHRNA7

5.49e-06282227129924
Pubmed

Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice.

CHRFAM7A CHRNA7

5.49e-06282217291692
Pubmed

Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice.

CHRFAM7A CHRNA7

5.49e-06282223521765
Pubmed

Effect of α7 nicotinic acetylcholine receptor activation on cardiac fibroblasts: a mechanism underlying RV fibrosis associated with cigarette smoke exposure.

CHRFAM7A CHRNA7

5.49e-06282228258105
Pubmed

The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation.

CHRFAM7A CHRNA7

5.49e-06282219344760
Pubmed

The implications of IDH mutations for cancer development and therapy.

IDH1 IDH2

5.49e-06282234131315
Pubmed

Enhancement of de novo lipogenesis by the IDH1 and IDH2-dependent reverse TCA cycle maintains the growth and angiogenic capacity of bone marrow-derived endothelial progenitor cells under hypoxia.

IDH1 IDH2

5.49e-06282238281628
Pubmed

Loss of α7nAChR enhances endothelial-to-mesenchymal transition after myocardial infarction via NF-κB activation.

CHRFAM7A CHRNA7

5.49e-06282235926661
Pubmed

The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.

CHRFAM7A CHRNA7

5.49e-06282217640819
Pubmed

Analysis of isocitrate dehydrogenase-1/2 gene mutations in gliomas.

IDH1 IDH2

5.49e-06282222166653
Pubmed

Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.

IDH1 IDH2

5.49e-06282223391413
Pubmed

Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure.

CHRFAM7A CHRNA7

5.49e-06282223431157
Pubmed

Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group.

IDH1 IDH2

5.49e-06282220625116
Pubmed

Insulin inhibits phagocytosis in normal human neutrophils via PKCalpha/beta-dependent priming of F-actin assembly.

PRKCA PRKCB

5.49e-06282216673150
Pubmed

Bidirectional Regulation of Aggression in Mice by Hippocampal Alpha-7 Nicotinic Acetylcholine Receptors.

CHRFAM7A CHRNA7

5.49e-06282229114104
Pubmed

Heterogeneity of cellular proliferation within transitional cell carcinoma: correlation of protein kinase C alpha/betaI expression and activity.

PRKCA PRKCB

5.49e-06282216517978
Pubmed

Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.

IDH1 IDH2

5.49e-06282229126125
Pubmed

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.

IDH1 IDH2

5.49e-06282220142433
Pubmed

Autophagy is Involved in Neuroprotective Effect of Alpha7 Nicotinic Acetylcholine Receptor on Ischemic Stroke.

CHRFAM7A CHRNA7

5.49e-06282233995108
Pubmed

E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation.

CHRFAM7A CHRNA7

5.49e-06282232552811
Pubmed

Effects of azidothymidine on protein kinase C activity and expression in erythroleukemic cell K562 and acute lymphoblastic leukemia cell HSB-2.

PRKCA PRKCB

5.49e-06282225693686
Pubmed

IDH1 and IDH2 mutations in gliomas.

IDH1 IDH2

5.49e-06282223532369
Pubmed

[IDH1/2 mutations in gliomas].

IDH1 IDH2

5.49e-06282222147457
Pubmed

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues.

IDH1 IDH2

5.49e-06282219915484
Pubmed

IDH2 compensates for IDH1 mutation to maintain cell survival under hypoxic conditions in IDH1‑mutant tumor cells.

IDH1 IDH2

5.49e-06282231257503
Pubmed

Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients.

IDH1 IDH2

5.49e-06282222033490
Pubmed

Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits.

CHRFAM7A CHRNA7

5.49e-06282224836856
Pubmed

Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors.

IDH1 IDH2

5.49e-06282224311631
Pubmed

Modulation of the MAPKs pathways affects Aβ-induced cognitive deficits in Alzheimer's disease via activation of α7nAChR.

CHRFAM7A CHRNA7

5.49e-06282231904546
Pubmed

Studies of sperm from mutant mice suggesting that two neurotransmitter receptors are important to the zona pellucida-initiated acrosome reaction.

CHRFAM7A CHRNA7

5.49e-06282215948184
Pubmed

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.

IDH1 IDH2

5.49e-06282223015095
Pubmed

Alpha7 nicotinic acetylcholine receptor mediates chronic nicotine inhalation-induced cardiopulmonary dysfunction.

CHRFAM7A CHRNA7

5.49e-06282235678315
Pubmed

Absence of IDH mutation in colorectal cancers with microsatellite instability.

IDH1 IDH2

5.49e-06282226987944
Pubmed

Age-Associated Tooth Loss and Oral Microbial Dysbiosis in a Mouse Genetic Model of Chronic Nicotine Exposure.

CHRFAM7A CHRNA7

5.49e-06282233117372
Pubmed

Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions.

IDH1 IDH2

5.49e-06282223111198
Pubmed

Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis.

CHRFAM7A CHRNA7

5.49e-06282212628457
Pubmed

Activation of α-7 nicotinic acetylcholine receptor reduces ischemic stroke injury through reduction of pro-inflammatory macrophages and oxidative stress.

CHRFAM7A CHRNA7

5.49e-06282225157794
Pubmed

Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.

CHRFAM7A CHRNA7

5.49e-06282219615981
Pubmed

Insular primary glioblastomas with IDH mutations: Clinical and biological specificities.

IDH1 IDH2

5.49e-06282228116838
Pubmed

Splenic nerve denervation attenuates depression-like behaviors in Chrna7 knock-out mice via the spleen-gut-brain axis.

CHRFAM7A CHRNA7

5.49e-06282238944290
Pubmed

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.

IDH1 IDH2

5.49e-06282220538800
Pubmed

The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.

IDH1 IDH2

5.49e-06282223264629
Pubmed

Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis.

IDH1 IDH2

5.49e-06282234516556
Pubmed

Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice.

CHRFAM7A CHRNA7

5.49e-06282228243714
Cytoband6q21

LIN28B CRYBG1 TUBE1

6.96e-04968236q21
Cytoband7p22.3

GPR146 SUN1

1.70e-03348227p22.3
GeneFamilyC2 domain containing protein kinases

PRKCA PRKCB PRKCH

4.10e-0610603835
GeneFamilyStAR related lipid transfer domain containing

STARD13 CERT1

1.11e-0315602759
GeneFamilyCD molecules|Mucins

MUC5B MUC2

2.18e-0321602648
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

AFMID CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

4.77e-0818581703f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 AACS PLCL1 IDH2

5.13e-0818781785e58a312fc325e4063a2d250666b99b8f99beb6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

9.54e-07180816eee71184ebed2694d3e60f579a44b3cf7dd2cd35
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

9.54e-07180816a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.05e-0618381631ab55d5f3639f5964541d5eae23044dbda3356e
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.12e-06185816898a093757f86be3e18d2ef1f16a71f50ef81dc3
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.16e-061868161850583d23903d08226aeb0edb3e07b0994330e4
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.16e-061868164dafc215c42e7949f932a3627359c107943b5d6b
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.19e-06187816b93cf4dfe8ffb89348ee7bccc9f284189f7240a2
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.19e-0618781652b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.31e-06190816b94df372bc08de11585b2467dba8c8fffff5cd92
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.31e-061908163dcadabbefe0128a5f30ab51234f049ab4d870c6
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.39e-06192816562df5e87038c500dd3a003fe5374cb31946b145
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.39e-06192816ee27d27e3d269764dbe8711d0b37ff9331a298a9
ToppCellControl-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class

ARHGEF40 LHFPL2 PRKCA PRKCB IDH2 RAB32

1.48e-061948167ab808dd1876b0eec2831caa16d04fd859b1dc50
ToppCellControl-Myeloid-MoAM4|Control / Condition, Lineage and Cell class

ARHGEF40 LHFPL2 PRKCA PRKCB IDH2 RAB32

1.52e-06195816211a736acbe875bd3c1942c62aaacc9b170ece6d
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.52e-061958163123e02d2894c83962ba402085b5e6422ebf8c73
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.61e-061978164ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.66e-06198816688b0eb5534dde40b8630ab8a3252c816711e02e
ToppCell15-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class

BMP1 MRC2 LHFPL2 MDK ANGPTL1 NRP1

1.66e-061988163d76393e72eed59b4dd16130ef5dd1d331ba5711
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1 IDH2

1.66e-061988164448d13511485a44fe7b549e4b8b6ad7637db624
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MBOAT1 PRKCA CRYBG1 MUC5B ERVMER34-1

8.31e-0615181510da94037225a71844281ddcb395072250a78094
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1

8.86e-061538150307f10e772021ae68a42690634df458672a6df9
ToppCellInt-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type

GPR146 OR2C3 PPM1J CRHR1 NRP1

1.28e-051658159803c3db6cdcf925bea7d9c382bf4fd05acf3509
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLCN5 PRSS12 LHFPL2 PRKCB LTB4R

1.35e-05167815f5bffa77061baec0ba87bd688a047595f32534db
ToppCellfacs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR146 CLCN5 PRKCA GRM8 NRP1

1.52e-051718156a0fafb8fd9fc7671618eeb2bf528ce8ce86b794
ToppCellfacs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR146 CLCN5 PRKCA GRM8 NRP1

1.52e-05171815e02b5831768dbb1b68998b672e55c9680ab0cc86
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC46A3 HTR7 OSBPL3 ACSS1 FANCA

1.60e-0517381515af4a0f7516dbf5c93ba66a19aca073ebe30d04
ToppCelldroplet-Marrow-nan-24m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAB38 PRSS12 PRKCA PRKCH PPM1J

1.65e-05174815955a3de6b7efc117f34c14faf8051f41454275dd
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

PLA2R1 LIN28B OTOGL PRSS12 GRM8

1.65e-05174815ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 PLCL1 IDH2

1.70e-05175815e5467dacf81f1f913b1719931cf1a7331434a7e7
ToppCellfacs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC46A3 HTR7 ACSS1 LTB4R RAB32

1.84e-051788158c5e9fab7b55a654ccaabf2c4d02397399d94616
ToppCellfacs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SLC46A3 HTR7 ACSS1 LTB4R RAB32

1.89e-05179815b7a2429d07d7146b32b3552a5f2a2542105a71e0
ToppCellfacs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR146 CLCN5 PRKCA GRM8 NRP1

1.94e-05180815839defb40f7cfb2711e9025194de636533f51bcd
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 PLCL1 IDH2

1.94e-051808159e09b3dfe344b5d50520711513d389865d73a861
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ARHGEF40 MRC2 CHRD LHFPL2 ITIH2

1.94e-0518081539ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

HTR7 PRKCA CRYBG1 PRKCH PLCL1

2.10e-05183815f2ef110bf29b1a8276ef216238363e542db262c1
ToppCellmyeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass

CLCN5 LHFPL2 PAPLN PPM1J NRP1

2.16e-0518481511619778bc773ecd1a9867330be04deaf324f31e
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HTR7 PRKCA CRYBG1 PRKCH PLCL1

2.16e-05184815bd786db4dc4edae6d5cfc0b69901983dea19f729
ToppCellnormal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CLCN5 OR2C3 LHFPL2 PPM1J NRP1

2.21e-051858153091870a5bf8ecb963e560b47c8502bae367416c
ToppCellmyeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|Dendritic_cell / Lineage, cell class and subclass

LHFPL2 PRKCB PAPLN PPM1J NRP1

2.27e-05186815858134580a09ed8a5eb6d6413d8ca9265904dfc1
ToppCell15-Trachea-Epithelial-Secretory_progenitor|Trachea / Age, Tissue, Lineage and Cell class

MUC5B MDK ERVMER34-1 ITIH2 NRP1

2.33e-05187815be9fce9e74b2f170a2067f1b31d802912a578329
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 KCNJ16 PLCL1 IDH2

2.45e-05189815f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

HTR7 PRKCA CRYBG1 PRKCH PLCL1

2.45e-051898159ab77c6fcb573854da5922412f53d2168bda6b58
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

HTR7 PRKCA CRYBG1 PRKCH PLCL1

2.45e-051898155a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCellPND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ARHGEF40 PRSS12 LHFPL2 MDK NRP1

2.52e-05190815947807863a9b247c301c6cf63d6fd5a2c8018e66
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 MRC2 PRKCA PRKCB NRP1

2.52e-051908152e592323085ba9c019d678ac2a784462ab470ed9
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 MRC2 PRKCA PRKCB NRP1

2.52e-05190815445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1

2.52e-05190815cc17ab84a9328124f146951c06be3eff9650d9fd
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 MRC2 PRKCA PRKCB NRP1

2.58e-05191815c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HTR7 PRKCA CRYBG1 PRKCH PLCL1

2.58e-05191815d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 OSBPL3 ACSS1 KCNJ16 PLCL1

2.58e-05191815963f4f2e852bbb4faf070aafb0d368297abacd3b
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

STARD13 MRC2 PRKCA PRKCB NRP1

2.58e-05191815cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCellPND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ARHGEF40 PRSS12 LHFPL2 MDK NRP1

2.58e-05191815db4943dd19207663fb9e27f8940fa4b06a933625
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 ACSS1 KCNJ16 PLCL1 IDH2

2.65e-051928158769b67d1cad1be65da3938f916e5bf88f88f6b8
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 ACSS1 KCNJ16 PLCL1 IDH2

2.65e-051928157af2b5240b1fad2177d8022e5f4fc1fe9e8f03b5
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PLA2R1 MRC2 CHRD PRKCA PRKCB

2.78e-05194815240d122dcb9dd1ab2867503ad85869853adcacae
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PLA2R1 MRC2 CHRD PRKCA PRKCB

2.78e-05194815ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

HTR7 PRKCA CRYBG1 PRKCH PLCL1

2.78e-05194815a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLCN5 ACSS1 KCNJ16 PLCL1 IDH2

2.92e-05196815e02301642243df483fd066d978317c113c04692b
ToppCellmild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

RSPH4A SLFN13 GPR52 PRKCH DEGS2

2.99e-05197815e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

BMP1 MRC2 SVIL ANGPTL1 NRP1

2.99e-051978152744cc94883c5d0424677cf5093bbab622933e9b
ToppCellSigmoid-(5)_Dendritic_cell-(51)_cDC1|Sigmoid / shred on region, Cell_type, and subtype

SLC46A3 HTR7 MRC2 PPM1J RAB32

3.22e-052008154ce0a2238c90622e41fd86ac4b7d82adf4af2c3b
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

MRC2 SVIL LHFPL2 MDK PFN2

3.22e-05200815eabb7d4aa92ace7d970bcd3fae2c7cb5400a43b4
ToppCell18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class

BMP1 MRC2 LHFPL2 MDK NRP1

3.22e-0520081514ae55660f7412518dcb5cb982f6fe9f23553cfb
ToppCellSigmoid-Dendritic_cell-cDC1|Sigmoid / Region, Cell class and subclass

SLC46A3 HTR7 MRC2 PPM1J RAB32

3.22e-052008153523ec986e8c9e176e08836c974b1de8b56d8b16
ToppCellBronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLA2R1 LIMK2 AACS MUC5B CHRNA7

3.22e-0520081585c0f038bcfb42669dca2b80273b0f8a1421405e
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PRSS12 PAPLN HAS3 NRP1

8.51e-05127814fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCellfrontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

KCNJ16 LHFPL2 BCAN MDK

1.02e-0413381463d2f096ae47d9b587acc6c5fbd346e5e58842b8
ToppCellPND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND01-03-samps / Age Group, Lineage, Cell class and subclass

PTPN5 TMED6 MDK CHRNA7

1.14e-0413781425b5370b63644351efddb8749ef174beca0581cd
ToppCellBAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

STARD13 RAB32 CHRFAM7A ANGPTL1

1.66e-0415181428e3f77d2edb30fcf1414762a55ceffaf879d526
ToppCellfacs-GAT-Fat-3m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OSBPL3 PRKCB PRKCH PPM1J

1.66e-041518143d07b79ecbcfad13116f0f2b039bd181a7ffe853
ToppCellBAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

STARD13 RAB32 CHRFAM7A ANGPTL1

1.66e-04151814688cc5e4d46ba16f9b431352d7a6d39b21941e9c
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

HTR7 MRC2 PRKCA PPM1J

1.66e-041518140b6b37734430918378ed94e40877f0c4ae9b25ec
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

HTR7 MRC2 PRKCA PPM1J

1.66e-0415181430225a1a7800b0ae19e16ac164f561379eedb99d
ToppCellBAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

STARD13 RAB32 CHRFAM7A ANGPTL1

1.66e-0415181445392bb1c6358beff33da0ca84f7696fb5824f30
ToppCellBAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

STARD13 RAB32 CHRFAM7A ANGPTL1

1.66e-041518143d861285c71abe220b19a069eb9876199c6c8f39
ToppCellMild_COVID-19-Myeloid-TRAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30)

STARD13 RAB32 CHRFAM7A ANGPTL1

1.79e-04154814ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64
ToppCell343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells)

OTOGL MUC5B MDK PFN2

1.93e-04157814dd08dc19d434e94a194076c462ee273c682abf55
ToppCellsevere_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2)

MBOAT1 HTR7 PPM1J NRP1

1.93e-04157814ec1978e07e2214048d015d8bb793c1d9991f6e37
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LIN28B SLFN13 OSBPL3 PRKCB

1.93e-04157814d12f343454202da86a06d0369f8ffe5662cd091b
ToppCell343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells)

OTOGL MUC5B MDK PFN2

1.93e-0415781470fd6c46db4250c7de5c4686a9500689402737f6
ToppCellE18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

AFMID LIN28B OSBPL3 PPM1J

1.97e-041588145d926be5a0ebe8257cd552afa7844171f9ff01c0
ToppCell3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

AFMID TMED6 MUC5B ERVMER34-1

2.07e-041608146005948e400e781cdb876ba350b3ec8991e3945f
ToppCellCOVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

CLCN5 LHFPL2 PPM1J NRP1

2.07e-0416081461f4cb4eb4313d8318aadbb99595a6cb7fd919f7
ToppCellCOVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

CLCN5 LHFPL2 PPM1J NRP1

2.07e-0416081434b4f710cfcb6ec370b8b074f3cbfe272f392cec
ToppCellLPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RSPH4A OSBPL3 MUC5B DEGS2

2.12e-04161814472c354f5ee148b37a5dfb795e83348ecb1643f1
ToppCellsevere-Myeloid-pDC|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

OR2C3 PAPLN PPM1J NRP1

2.12e-041618149e8e8ac11f7fb8c8697357c21034b613f191db2b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PRKCA CRYBG1 PRKCH PLCL1

2.44e-0416781483969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCelldroplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPR146 SLC46A3 HTR7 PEPD

2.49e-041688142c996d09b6a8ccd3c708146eca310b02eafff425
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFMID CHRD LTB4R RAB32

2.55e-0416981415a9183c838cc6384d7f5dfeae3d30602964c9b3
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MBOAT1 PRKCA CRYBG1 GRM8

2.55e-041698140332f539a2f7d6dcd081a5d2f567290721f5a329
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

RAB38 AFMID DGLUCY TUBE1

2.55e-04169814f086b50791e1c93e253eb5e8d6c4bf617b1416c3
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RAB38 OTOGL PAPLN PLCL1

2.61e-041708145570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMED6 MBOAT1 PRKCA RAB32

2.67e-041718145885e69e997cc2f6a27afebfe57001ca0ac062a6
ToppCellSubstantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

PLA2R1 OTOGL RRH

2.70e-0469813a157b1582401cebd222343d94086dbea876140c2
ToppCellSubstantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

PLA2R1 OTOGL RRH

2.70e-0469813cdd42abdd072aa438830d837ee857529269a81e0
ToppCelldroplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPN5 MBOAT1 RRH ITIH2

2.73e-04172814c0bda7153e02bee7d0326138cc684151c404c2a1
ToppCelldroplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SLC46A3 HTR7 LTB4R RAB32

2.79e-04173814f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TPRA1 CLCN5 GPATCH3 PEPD

2.79e-0417381426bba58f9fb215d1d155504906cd77e8774f6936
Drugsoman

AFMID PEPD PRKCA PRKCB PRKCH CHRFAM7A CHRNA7

3.80e-0892817CID000007305
Drug2-amino-3-phosphonopropionic acid

AFMID PRKCA PRKCB PRKCH MDK GRM8

3.01e-0776816CID000003857
DrugNSC150531

PRKCA PRKCB PRKCH IDH1 PFN2

8.48e-0749815CID000004475
Drugpentobarbital

AFMID HTR7 SLFN13 PRKCA PRKCB PRKCH CHRFAM7A CHRNA7

1.34e-06224818CID000004737
Drugpseudohypericin

PRKCA PRKCB PRKCH CRHR1

2.45e-0627814CID005281751
DrugNCDC

HTR7 PRKCA PRKCB PRKCH

2.85e-0628814CID000001583
DrugCGS 9343B

HTR7 PRKCA PRKCB PRKCH

5.62e-0633814CID000065909
DrugMegestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A

STARD13 MRC2 DNAH17 SUN1 ZZEF1 MEAK7 NRP1

6.18e-061958173091_UP
Drugh x mg

PRKCA PRKCB PRKCH LTB4R

6.36e-0634814CID000001380
DrugHymecromone [90-33-5]; Up 200; 22.8uM; PC3; HT_HG-U133A

BMP1 HTR7 PRSS12 ELOVL5 PRKCA IDH2 GRM8

6.39e-061968174623_UP
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; HL60; HT_HG-U133A

MRC2 OSBPL3 SVIL AACS LTB4R IDH2 TBL1X

6.83e-061988172346_DN
Drugacetate

ACSS1 DNAH17 PEPD AACS PRKCA PRKCB PRKCH IDH1 IDH2 PFN2 FANCA

8.72e-065998111CID000000175
DrugAC1L19KJ

ACSS1 IDH1 IDH2

9.33e-0612813CID000000589
Drugmethacholine

PLA2R1 PRKCA PRKCB PRKCH LTB4R CHRFAM7A CHRNA7

1.24e-05217817CID000001993
Drugalpha-naphthylthiourea

PTPN5 AFMID PEPD CHRFAM7A CHRNA7

1.25e-0584815CID000736366
DrugNSC729646

PRKCA MDK

1.25e-052812CID006476334
Drug12-hydroxydaphnetoxin

PRKCA PRKCB

1.25e-052812CID000099841
Drugquinuclidinyl benzilate

PRKCA PRKCB PRKCH CHRFAM7A CHRNA7

1.48e-0587815CID000023056
Drugbenzenesulfonate

PRKCA PRKCB PRKCH CRHR1

1.50e-0542814CID000007371
Drugtetracaine

PRKCA PRKCB PRKCH CHRFAM7A CHRNA7

1.56e-0588815CID000005411
Drug25(OH) vitamin D3

PTPN5 CLCN5 PRKCA PRKCB PRKCH ITIH2

1.60e-05150816CID000001593
DrugC6-ceramide

PTPN5 LIMK2 PRKCA PRKCB PRKCH

1.65e-0589815CID000375405
Drugprocaine

PRKCA PRKCB PRKCH TUBE1 CHRFAM7A CHRNA7

1.79e-05153816CID000004914
DrugRK-1409B

PRKCA PRKCB PRKCH

1.91e-0515813CID003036125
Drug1-stearoyl-2-arachidonylglycerol

PRKCA PRKCB PRKCH

1.91e-0515813CID006443869
Drugdansyl-DAG

PRKCA PRKCB PRKCH

1.91e-0515813CID000129493
DrugAC1L18QD

AFMID HTR7 RRH PRKCA PRKCB PRKCH BCAN LTB4R

2.06e-05325818CID000000213
DrugAC1O517G

PRKCA PRKCB MDK

2.35e-0516813CID006450188
Drugmetalaxyl

AFMID BMP1 IDH2

2.35e-0516813CID000042586
DrugGDP-b-S

NTSR2 PRKCA PRKCB PRKCH GRM8 TBL1X

2.47e-05162816CID000643998
Drugphorbol 12,13-diacetate

PRKCA PRKCB PRKCH GRM8

2.57e-0548814CID000072293
Drugpropiverine

PRKCA PRKCB PRKCH CHRFAM7A CHRNA7

2.77e-0599815CID000004942
Drugcadmium

AFMID BMP1 PRKCA PRKCB PRKCH IDH1 IDH2 GRM8 ITIH2

2.79e-05443819CID000002514
DrugAC1L1JQC

PRKCA PRKCB PRKCH

2.85e-0517813CID000005157
Drugdaphnoretin

PRKCA PRKCB PRKCH

2.85e-0517813CID005281406
Drugmepivacaine

PEPD PRKCA PRKCB PRKCH

3.27e-0551814CID000004062
Drugglutamate

APIP CLCN5 HTR7 KCNJ16 PRKCA PRKCB PRKCH IDH1 IDH2 MDK GRM8 CHRFAM7A CHRNA7

3.29e-059628113CID000000611
Drugdihydrosterculic acid

PRKCA PRKCB PRKCH

3.41e-0518813CID000160788
Drugdipalmitin

PRKCA PRKCB PRKCH

3.41e-0518813CID000068149
DrugCgp-42700

PRKCA PRKCB PRKCH

3.41e-0518813CID000188390
Drugoctahydromezerein

PRKCA PRKCB

3.74e-053812CID000164152
DrugTAPP-Br

PRKCA PRKCB PRKCH

4.03e-0519813CID000160326
Drugsapintoxin A

PRKCA PRKCB PRKCH

4.03e-0519813CID000108085
DrugCortisporin

AACS PRKCA PRKCB PRKCH CHRFAM7A CHRNA7

4.06e-05177816CID000004454
Drugmangrove

ACSS1 AACS PRKCA PRKCB PRKCH IDH1 IDH2 CHRFAM7A CHRNA7

4.27e-05468819CID000000965
DrugN-(6-aminohexyl)-1-naphthalenesulfonamide

AFMID PRKCA PRKCB PRKCH

5.09e-0557814CID000004314
DrugMDL 27,032

PRKCA PRKCB PRKCH

5.51e-0521813CID000163812
DrugKS-619-1

PRKCA PRKCB PRKCH

5.51e-0521813CID000128369
DrugK-259-2

PRKCA PRKCB PRKCH

5.51e-0521813CID006438946
Drugdebromoaplysiatoxin

PRKCA PRKCB PRKCH

5.51e-0521813CID000002967
Drugbroussochalcone A

PRKCA PRKCB PRKCH

5.51e-0521813CID006438825
Drugclozapine

HTR7 NTSR2 PRKCA PRKCB PRKCH CHRFAM7A CHRNA7

5.51e-05274817CID000002818
DrugDPCPX

AFMID PRKCA PRKCB PRKCH GRM8

6.17e-05117815CID000001329
Drugtautomycin

CLCN5 PRKCA PRKCB PRKCH DEGS2

6.43e-05118815CID000440646
DrugFlurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A

SLC46A3 MRC2 DNAH17 ELOVL5 PRKCH LTB4R

6.96e-051958165269_DN
Drugnordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A

SVIL SUN1 ELOVL5 PRKCA TBL1X SENP5

7.16e-051968161164_DN
DrugIsosorbide dinitrate [87-33-2]; Up 200; 17uM; PC3; HT_HG-U133A

BMP1 LIMK2 MUC5B NRP1 SENP5 FANCA

7.16e-051968163720_UP
DrugProcyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; HL60; HT_HG-U133A

HTR7 PRSS12 MRC2 OSBPL3 PFN2 MUC2

7.16e-051968162991_DN
Drugclozapine; Up 200; 10uM; PC3; HT_HG-U133A

PLA2R1 HTR7 ADAM20 MRC2 GRM8 MUC2

7.16e-051968164453_UP
DrugAC1L4NFY

PRKCA PRKCB PRKCH

7.30e-0523813CID000160335
Drugdaphnetoxin

PRKCA PRKCB

7.47e-054812CID000119454
DrugAC1NS0D7

PRKCA MDK

7.47e-054812CID005326345
Drugmyristyl acetate

PRKCA PRKCB PRKCH LTB4R

7.55e-0563814CID000012531
DrugFlunixin meglumine [42461-84-7]; Up 200; 8.2uM; PC3; HT_HG-U133A

DGLUCY LIMK2 PRSS12 PRKCB ZZEF1 SENP5

7.57e-051988163713_UP
DrugCyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; PC3; HT_HG-U133A

LIMK2 HTR7 SVIL IDH2 GRM8 NRP1

7.57e-051988164252_DN
DrugProcarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; HL60; HT_HG-U133A

ARHGEF40 GPATCH3 HTR7 PLCL1 LTB4R NRP1

7.57e-051988162971_UP
DrugNefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; PC3; HT_HG-U133A

LIMK2 PRKCH LTB4R CRHR1 NRP1 FANCA

7.78e-051998163730_UP
Drugtolbutamide; Up 200; 100uM; MCF7; HG-U133A

PEPD IDH2 SLC30A1 MEAK7 TBL1X FANCA

7.78e-05199816142_UP
DrugPNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A

LIMK2 ARHGEF40 PRSS12 MRC2 DNAH17 NRP1

8.00e-052008163735_UP
DrugSaquinavir mesylate [149845-06-7]; Down 200; 5.2uM; HL60; HT_HG-U133A

CLCN5 GPATCH3 MRC2 PRKCA BCAN ITIH2

8.00e-052008166127_DN
Drugcurarine

CHRFAM7A CHRNA7 FANCA

1.06e-0426813CID000198004
DrugPc 12

PRKCA PRKCB PRKCH SLC30A1 CHRFAM7A CHRNA7

1.07e-04211816CID003036508
DrugC15720

PRKCA PRKCB PRKCH

1.19e-0427813CID000003979
Drugbeta-tocopherol

PRKCA PRKCB PRKCH

1.19e-0427813CID000008989
Drugilmofosine

PRKCA PRKCB PRKCH

1.19e-0427813CID000055008
DrugAC1L1HLA

PRKCA PRKCB PRKCH LTB4R

1.20e-0471814CID000004179
Drug3-amino-2-oxopropyl phosphate

IDH1 IDH2

1.24e-045812CID000000005
Drug3-ethylmalate

IDH1 IDH2

1.24e-045812CID000439619
Drug12-deoxyphorbolphenylacetate-20-acetate

PRKCA PRKCB

1.24e-045812ctd:C029705
DrugBDTD

IDH1 IDH2

1.24e-045812CID003036435
Drugadenosine 5'-(2-bromoethyl)-phosphate

IDH1 IDH2

1.24e-045812CID000194660
Drughalothane

PRKCA PRKCB PRKCH LTB4R ZZEF1 CHRFAM7A CHRNA7

1.29e-04314817CID000003562
Drugbisindolylmaleimide II

PRKCA PRKCB PRKCH

1.33e-0428813CID000002397
Drugbisindolylmaleimide V

PRKCA PRKCB PRKCH

1.33e-0428813CID000002400
Drugaplysiatoxin

PRKCA PRKCB PRKCH

1.33e-0428813CID000040465
DrugHBDDE

PRKCA PRKCB PRKCH

1.33e-0428813CID000003568
Drugechothiophate

AFMID CHRFAM7A CHRNA7

1.33e-0428813CID000010547
DrugSC-10

PRKCA PRKCB PRKCH

1.33e-0428813CID000005175
Drugmyo-inositol

HTR7 NTSR2 PRKCA PRKCB PRKCH PLCL1 LTB4R GRM8 CHRFAM7A CHRNA7 TBL1X

1.37e-048118111CID000000892
Drugtetradotoxin

HTR7 NTSR2 PRKCA PRKCB PRKCH GRM8 CHRFAM7A CHRNA7

1.42e-04428818CID000020382
DrugAC1Q6DXY

PRKCA PRKCB PRKCH

1.48e-0429813CID000003719
DrugAC1L1B58

PRKCA PRKCB PRKCH

1.48e-0429813CID000001288
DrugPolychlorinated biphenyls

PRKCA PRKCB PRKCH

1.48e-0429813CID000006636
Drugfluoxetine

HTR7 MDK CHRFAM7A CRHR1 CHRNA7 NRP1

1.52e-04225816CID000003386
Drugserotonin

AFMID CLCN5 HTR7 PRKCA PRKCB PRKCH CHRFAM7A CRHR1 CHRNA7

1.54e-04554819CID000005202
DrugBAPTA

NTSR2 PRKCA PRKCB PRKCH GRM8 CHRFAM7A CHRNA7

1.56e-04324817CID000104751
DrugGf 109

PRKCA PRKCB PRKCH

1.64e-0430813CID000196144
DrugAC1L3G0K

PRKCA PRKCB PRKCH

1.64e-0430813CID000114822
Drug12-deoxyphorbol 13-phenylacetate

PRKCA PRKCB PRKCH

1.64e-0430813CID000105100
Drug8-CPT-cAMP

PRKCA PRKCB PRKCH HAS3 GRM8

1.64e-04144815CID000001903
Diseasecognitive disorder (implicated_via_orthology)

HTR7 CHRFAM7A CHRNA7

3.67e-076793DOID:1561 (implicated_via_orthology)
DiseaseAnxiety States, Neurotic

HTR7 MDK GRM8 CRHR1

5.95e-0644794C0376280
DiseaseAnxiety Disorders

HTR7 MDK GRM8 CRHR1

5.95e-0644794C0003469
DiseaseAnxiety neurosis (finding)

HTR7 MDK GRM8 CRHR1

5.95e-0644794C1279420
Diseasehepatocellular clear cell carcinoma (is_implicated_in)

IDH1 IDH2

7.08e-062792DOID:5016 (is_implicated_in)
DiseaseEnchondroma

IDH1 IDH2

7.08e-062792C1704356
DiseaseChondroma

IDH1 IDH2

7.08e-062792C0936248
DiseaseMaffucci Syndrome

IDH1 IDH2

2.12e-053792C0024454
DiseaseChorioangioma

IDH1 IDH2

4.23e-054792C0677608
DiseaseAngioma

IDH1 IDH2

4.23e-054792C1959588
DiseaseEnchondromatosis

IDH1 IDH2

4.23e-054792C0014084
DiseaseHemangioma

IDH1 IDH2

4.23e-054792C0018916
DiseaseHemangioma, Intramuscular

IDH1 IDH2

4.23e-054792C0205789
DiseaseHistiocytoid hemangioma

IDH1 IDH2

4.23e-054792C0205788
Diseaserheumatoid arthritis (biomarker_via_orthology)

CHRFAM7A CHRNA7

1.05e-046792DOID:7148 (biomarker_via_orthology)
DiseaseBiliary Tract Neoplasm

IDH1 IDH2

1.05e-046792C0005426
DiseaseChildhood Oligodendroglioma

IDH1 IDH2

1.47e-047792C0280475
DiseaseAdult Oligodendroglioma

IDH1 IDH2

1.47e-047792C0279070
DiseaseNAD-dependent protein deacetylase sirtuin-2 measurement

PRKCA ITIH2

1.47e-047792EFO_0008241
DiseaseOligodendroblastoma

IDH1 IDH2

1.47e-047792C0344461
DiseaseMixed Oligodendroglioma-Astrocytoma

IDH1 IDH2

1.47e-047792C0280793
DiseaseMixed Oligodendroglioma-Ependymoma

IDH1 IDH2

1.47e-047792C0751395
DiseaseWell Differentiated Oligodendroglioma

IDH1 IDH2

1.47e-047792C0751396
Diseaseoligodendroglioma

IDH1 IDH2

1.96e-048792C0028945
Diseaseirritable bowel syndrome (biomarker_via_orthology)

HTR7 CRHR1

1.96e-048792DOID:9778 (biomarker_via_orthology)
DiseaseAnaplastic Oligodendroglioma

IDH1 IDH2

1.96e-048792C0334590
DiseaseMemory Loss

HTR7 MDK CHRNA7

2.11e-0443793C0751295
DiseaseAge-Related Memory Disorders

HTR7 MDK CHRNA7

2.11e-0443793C0751292
DiseaseMemory Disorder, Spatial

HTR7 MDK CHRNA7

2.11e-0443793C0751294
DiseaseMemory Disorder, Semantic

HTR7 MDK CHRNA7

2.11e-0443793C0751293
DiseaseMemory Disorders

HTR7 MDK CHRNA7

2.11e-0443793C0025261
Diseasehigh grade glioma (implicated_via_orthology)

BCAN IDH1 IDH2

2.26e-0444793DOID:3070 (implicated_via_orthology)
DiseaseMemory impairment

HTR7 MDK CHRNA7

2.26e-0444793C0233794
DiseaseGlioblastoma Multiforme

PRKCA PRKCB IDH1 IDH2

2.29e-04111794C1621958
Diseaseesophagus squamous cell carcinoma (is_implicated_in)

IDH2 CHRNA7 FANCA

2.42e-0445793DOID:3748 (is_implicated_in)
DiseaseIntestinal Neoplasms

PRKCA MUC2

4.59e-0412792C0021841
DiseaseIntestinal Cancer

PRKCA MUC2

4.59e-0412792C0346627
Diseasenicotine dependence (implicated_via_orthology)

CHRFAM7A CHRNA7

4.59e-0412792DOID:0050742 (implicated_via_orthology)
DiseaseHematologic Neoplasms

IDH1 IDH2

4.59e-0412792C0376545
Diseaselung non-small cell carcinoma (is_implicated_in)

PRKCB IDH2 CHRNA7 NRP1

5.39e-04139794DOID:3908 (is_implicated_in)
Diseaseworry measurement

PLCL1 CLP1 GRM8 CRHR1

7.91e-04154794EFO_0009589
Diseaseschizophrenia (implicated_via_orthology)

MDK CHRFAM7A CHRNA7

8.17e-0468793DOID:5419 (implicated_via_orthology)
DiseaseNonorganic psychosis

PRKCA GPR52 CRHR1

8.52e-0469793C0349204
DiseaseMalignant Glioma

CLCN5 IDH1 MDK

8.89e-0470793C0555198
Diseasemixed gliomas

CLCN5 IDH1 MDK

8.89e-0470793C0259783
Diseaseage at onset, Parkinson disease

KLHDC1 LHFPL2

1.05e-0318792EFO_0004847, MONDO_0005180
Diseaseischemia (biomarker_via_orthology)

PRKCA MUC2

1.05e-0318792DOID:326 (biomarker_via_orthology)
DiseaseDyschondroplasias

IDH1 IDH2

1.18e-0319792C0013366
Diseaseresponse to methotrexate, neurotoxicity

MBOAT1 PLCL1

1.18e-0319792EFO_0011057, GO_0031427
DiseaseLeukemia, Myelocytic, Acute

SVIL IDH1 IDH2 FANCA

1.22e-03173794C0023467
DiseaseCardiac Hypertrophy

PRKCA PRKCB IDH2

1.40e-0382793C1383860
DiseaseCardiomegaly

PRKCA PRKCB IDH2

1.40e-0382793C0018800
Diseaseacute myeloid leukemia (is_implicated_in)

IDH1 IDH2 FANCA

1.51e-0384793DOID:9119 (is_implicated_in)
DiseaseGlioma

CLCN5 IDH1 MDK

1.67e-0387793C0017638
DiseaseIntrahepatic Cholangiocarcinoma

IDH1 IDH2

1.88e-0324792C0345905
DiseaseExtrahepatic Cholangiocarcinoma

IDH1 IDH2

1.88e-0324792C3805278
Diseasealcohol use disorder (implicated_via_orthology)

PRKCA PRKCB GPR52 PRKCH

1.89e-03195794DOID:1574 (implicated_via_orthology)
DiseaseCholangiocarcinoma

IDH1 IDH2

2.21e-0326792C0206698
DiseaseAdenocarcinoma of large intestine

PRKCA PRKCB PRKCH

2.21e-0396793C1319315
DiseaseAnaplastic astrocytoma

IDH1 IDH2

2.38e-0327792C0334579
DiseaseVisual seizure

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0270824
DiseaseEpileptic drop attack

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0270846
DiseaseGeneralized seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0234533
DiseaseClonic Seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0234535
DiseaseVertiginous seizure

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0422855
DiseaseGustatory seizure

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0422854
DiseaseSeizures, Somatosensory

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0422850
DiseaseOlfactory seizure

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0422853
DiseaseSeizures, Auditory

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0422852
DiseaseGeneralized Absence Seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C4505436
DiseaseConvulsive Seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0751494
DiseaseSeizures, Sensory

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0751496
DiseaseJacksonian Seizure

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0022333
DiseaseNon-epileptic convulsion

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0751056
DiseasePsychotic Disorders

PRKCA GPR52 CRHR1

2.55e-03101793C0033975
DiseaseAtonic Absence Seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0751123
DiseaseComplex partial seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0149958
DiseaseSingle Seizure

IDH2 SLC30A1 CHRNA7

2.55e-03101793C0751110
DiseaseEpileptic Seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C4317109
DiseaseNonepileptic Seizures

IDH2 SLC30A1 CHRNA7

2.55e-03101793C3495874
DiseaseTonic Seizures

IDH2 SLC30A1 CHRNA7

2.62e-03102793C0270844
DiseaseAbsence Seizures

IDH2 SLC30A1 CHRNA7

2.62e-03102793C4316903
DiseaseConvulsions

IDH2 SLC30A1 CHRNA7

2.62e-03102793C4048158

Protein segments in the cluster

PeptideGeneStartEntry
FGCVADIGWITGHSY

ACSS1

331

Q9NUB1
ACAQYSGFLFFHEGW

ARHGEF40

66

Q8TER5
YFSKFPGIWAHGDYC

AACS

511

Q86V21
FGHCGIVGTTYVKCW

ADAM20

541

O43506
DMYAGNCAHFHKGGW

ANGPTL1

426

O95841
NWVGKGFFAVYEAIC

BMP1

421

P13497
VQHCKLKFGSWSYGG

CHRNA7

161

P36544
VCSTWGDFHYKTFDG

MUC5B

76

Q9HC84
FHWAFGVTEPGCYGV

PEPD

71

P12955
FCKEHGFAGWFETSA

RAB32

161

Q13637
FCKEHGFVGWFETSA

RAB38

146

P57729
FLFFHGGYWQSGSKD

AFMID

91

Q63HM1
DLYGSWKFGYAGCQV

RRH

86

O14718
WKFGYAGCQVYAGLN

RRH

91

O14718
FLLACGVLWFSGYGH

PTPN5

96

P54829
KGVTGHEVCNYFWNV

CERT1

451

Q9Y5P4
GWDAFQGACYKHFST

BCAN

691

Q96GW7
IAKAWHQAYFGEGSG

PRSS12

326

P56730
GGGFLAFYNCQLSWS

NEIL2

171

Q969S2
CWFVHNSGKGFIDGH

ITIH2

916

P19823
WVFGDLGCRGYYFVH

NTSR2

101

O95665
GVWEGKYNFFCQGTR

ELOVL5

86

Q9NYP7
FVMNWVPCGHSYFGA

ELOVL5

156

Q9NYP7
PKDYWGKFGEFCHGC

LIMK2

61

P53671
YKFENWGACDGGTGT

MDK

86

P21741
NLFCSYGLTEAHGKW

ERVMER34-1

246

Q9H9K5
TGHCKWFNVRMGFGF

LIN28B

31

Q6ZN17
KGGSGLVFYTDAQFW

GPATCH3

331

Q96I76
VCSTWGNFHYKTFDG

MUC2

36

Q02817
AGWGCQKAIDYCGHY

LHFPL2

156

Q6ZUX7
FKYDNQWFHGCTSTG

MRC2

191

Q9UBG0
SHCTDFIWGFGKQGF

PRKCB

51

P05771
NYFGLWVDVDFGKGH

MEAK7

366

Q6P9B6
GGCVVQFYISHWLGA

OR2C3

96

Q8N628
EFWEENFGCKLGSHG

GRM8

361

O00222
GKPGYHGDIFEWCAT

GPR52

181

Q9Y2T5
VQHCKLKFGSWSYGG

CHRFAM7A

71

Q494W8
HFLAQGTWSFGLAGC

LTB4R

76

Q15722
YGFNCEFGWGSHKTF

NRP1

646

O14786
CDAKYVWAATAGGVF

PFN2

26

P35080
EFYLLGFGAQHEFWC

OR5AK2

11

Q8NH90
SEGGFIWACKNYDGD

IDH1

261

O75874
SGGFVWACKNYDGDV

IDH2

301

P48735
YKGLAQTGAWGCFDE

DNAH17

1886

Q9UFH2
VKWQAGVCYNGGKDF

DELEC1

41

Q9P2X7
WFKASFGSTRGYHGC

FANCA

451

O15360
KEGICTGGFWFNHEH

CLCN5

156

P51795
FWAYAFGGCVNHSLT

DEGS2

71

Q6QHC5
NFFWMFGEGCYLHTA

CRHR1

231

P34998
GFGFSGVDKNGNFCW

MBOAT1

311

Q6ZNC8
HCAVVDGNFLYVWGG

KLHDC1

16

Q8N7A1
DWYHQKFLGSKCSFG

HAS3

301

O00219
KGFYTSFEDWGGKNC

CRYBG1

1381

Q9Y4K1
QFWKYEFGACTGSLA

DGLUCY

91

Q7Z3D6
VYNTRHVCGFVWGGA

GPR146

141

Q96CH1
PAGGYFWCNFTLTKH

ERVFC1

326

P60507
HGRCFYIFVKSWSGD

SLFN13

101

Q68D06
GICKTWGQYHFETFD

OTOGL

121

Q3ZCN5
FGKWHESIYCGGGSS

OSBPL3

751

Q9H4L5
LCKQFYHLGWVTGTG

APIP

31

Q96GX9
SNGKKFENFYIGWGH

RSPH4A

636

Q5TD94
WYSKGFGHLCAAEVA

STARD13

1081

Q9Y3M8
AGKEKCVYFFWQGRH

SVIL

1806

O95425
SHCTDFIWGFGKQGF

PRKCA

51

P17252
FIGAFCGNYTTFWGA

SLC46A3

136

Q7Z3Q1
GQGLCFYYWGLFDGH

PPM1J

146

Q5JR12
QEGWERHGGFCYKID

PLA2R1

516

Q13018
FHFTGKWYFEDCGKE

PLA2R1

1076

Q13018
TDLIGGKWIFGHFFC

HTR7

141

P34969
GKWIFGHFFCNVFIA

HTR7

146

P34969
CGWVKGSGYQALVHA

CLP1

231

Q92989
CTFGGKVYALDETWH

CHRD

51

Q9H2X0
HSYRGTGGIFEVCWN

TBL1X

541

O60907
HTGWFLQNGGCGYVL

PLCL1

681

Q15111
YGHGGRQFWLVSSCF

TPRA1

186

Q86W33
WNTGFGGFKKFYFHQ

SENP5

21

Q96HI0
RFWYGGCHGNANNFA

PAPLN

781

O95428
GNNWAVGHKVFGSLY

TUBE1

106

Q9UJT0
VSGDEKGVVFCYWFN

GEMIN5

126

Q8TEQ6
GSCNVYFKHIFGEWG

KCNJ16

41

Q9NPI9
GGTECFWQFAHQTGY

TMED6

51

Q8WW62
HNEWGYKFTVTACGL

ZZEF1

1181

O43149
GNCWAFKGSQGYLVV

SUN1

666

O94901
ALVFYFSWKGCSEGD

SLC30A1

266

Q9Y6M5
ICGQCGLAFKWSSHY

ZNF628

121

Q5EBL2
SHCREFIWGVFGKQG

PRKCH

186

P24723
FIWGVFGKQGYQCQV

PRKCH

191

P24723